FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to chronomedicine, endocrinology, dietology, therapy. Following actigraphy parameters are taken into account: circadian amplitude, blue light phase position, activity phase-to-wrist temperature ratio (bathyphase), ratio of activity phase to light phase, index of relative melanopic deficiency of daylight, index of excess of evening blue light. Based on the quantitative assessment, the patient can be given recommendations depending on the values that are outside the optimum.
EFFECT: method makes it possible to estimate circadian equilibrium according to actigraphy data.
1 cl, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE USING ACTIGRAPHY | 2024 |
|
RU2830419C1 |
| METHOD FOR INTEGRATIVE ASSESSMENT OF SLEEP IN ACTIGRAPHY | 2024 |
|
RU2833895C1 |
| METHOD FOR ASSESSING INDIVIDUAL METABOLIC RISK BY CIRCADIAN LIGHT HYGIENE | 2024 |
|
RU2828989C1 |
| METHOD FOR DETERMINING BLOOD TRIGLYCERIDES TAKING INTO ACCOUNT BIOLOGICAL CLOCK PHASE | 2024 |
|
RU2834162C1 |
| METHOD OF ASSESSING SLOWING OF BIOLOGICAL CLOCK BASED ON RELATIVE EVENING AND NIGHT MELANOPIC LIGHT LOAD | 2023 |
|
RU2807915C1 |
| METHOD FOR DIAGNOSING TRUE VALUE OF HIGH-DENSITY LIPOPROTEINS TAKING INTO ACCOUNT BLUE LIGHT PHASE | 2024 |
|
RU2834161C1 |
| METHOD FOR DIAGNOSIS OF LIGHT DESYNCHRONOSIS | 2020 |
|
RU2748686C1 |
| METHOD OF ASSESSING BIOLOGICAL CLOCK SHIFT BASED ON RELATIVE DAYTIME MELANOPIC LIGHT LOAD | 2023 |
|
RU2807913C1 |
| METHOD OF ASSESSING LEVEL OF EVENING MELANOPIC LIGHT LOAD | 2023 |
|
RU2812591C1 |
| METHOD FOR ESTIMATING THE RISK OF OCCURRENCE OF PSYCHOLOGICAL SLEEP AND MOOD DISORDERS BASED ON THE ADJUSTED AVERAGE SLEEP STAGE ACCORDING TO THE MUNICH QUESTIONNAIRE | 2021 |
|
RU2762914C1 |
